TEMPORAL RESPONSE PATTERNS OF ABROCITINIB AND DUPILUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF THE JADE DARE TRIAL

被引：0
|
作者：
Trzeciak, Magdalena [1 ]
Chovatiya, Raj [2 ]
Geng, Bob [3 ]
Biswas, Pinaki [4 ]
Guler, Erman [5 ]
机构：
[1] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland
[2] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL USA
[3] Univ Calif San Diego, Dept Dermatol, Sch Med, San Diego, CA USA
[4] Pfizer Inc, New York, NY USA
[5] Pfizer Inc, Istanbul, Turkiye
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P4.6
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [1] Depth and rapidity of response with abrocitinib and dupilumab in patients with moderate-to-severe atopic dermatitis in JADE COMPARE
    Lio, P.
    Boguniewicz, M.
    Alexis, A.
    Lebwohl, M.
    Reich, K.
    Pink, A.
    Kabashima, K.
    Bissonnette, R.
    Nowicki, R. J.
    Valdez, H.
    Zhang, F.
    DiBonaventura, M.
    Clibborn, C.
    Cameron, M. C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E138 - E139
  • [2] Efficacy and Safety of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the Presence or Absence of Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE
    Thyssen, Jacob P.
    Silverberg, Jonathan I.
    Yosipovitch, Gil
    Kwatra, Shawn G.
    Carrascosa, Jose-Manuel
    Brunner, Patrick M.
    Lazariciu, Irina
    Feeney, Claire
    Rebollo, Francisco J.
    Koppensteiner, Herwig
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB156 - AB156
  • [3] Effect of Abrocitinib and Dupilumab on Eosinophil Levels in Patients With Moderate-to-Severe Atopic Dermatitis and With or Without Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE
    Geng, Bob
    Nosbaum, Audrey
    Boguniewicz, Mark
    Lazariciu, Irina
    Feeney, Claire
    Rebollo, Francisco
    Koppensteiner, Herwig
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB153 - AB153
  • [4] Onset and depth of response with abrocitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the phase IIIb JADE DARE clinical trial
    Reich, K.
    Valenzuela, F.
    Hong, H. C.
    Eyerich, K.
    Rice, Z. Pressley
    Bhambri, A.
    Gueler, E.
    Zhang, F.
    Rojo, R.
    Chan, G.
    Clibborn, C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E170 - E170
  • [5] Depth and Rapidity of Response With Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis (AD) in JADE COMPARE
    Lio, Peter
    Boguniewicz, Mark
    Alexis, Andrew
    Lebwohl, Mark
    Reich, Kristian
    Pink, Andrew
    Kabashima, Kenji
    Bissonnette, Robert
    Nowicki, Roman
    Valdez, Hernan
    Zhang, Fan
    DiBonaventura, Marco
    Clibborn, Claire
    Cameron, Michael
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB34 - AB34
  • [6] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
    Li, Hang
    Cheng, Hao
    Lu, Qianjin
    Lai, Wei
    Tao, Xiaohua
    Encinas, Gerardo A.
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    [J]. CHINESE MEDICAL JOURNAL, 2024, 137 (16) : 1991 - 1992
  • [7] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
    Li Hang
    Cheng Hao
    Lu Qianjin
    Lai Wei
    Tao Xiaohua
    Encinas Gerardo A
    Vyas Shefali
    Wang Bo
    Luo Xin
    Li Shiqi
    [J]. 中华医学杂志英文版., 2024, 137 (16)
  • [8] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of the JADE REGIMEN phase 3 trial
    Li, Hang
    Cheng, Hao
    Lu, Qianjin
    Lai, Wei
    Tao, Xiaohua
    Encinas, Gerardo A.
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [9] EFFICACY AND SAFETY OF ABROCITINIB MONOTHERAPY IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF JADE REGIMEN
    Flohr, Carsten
    Cork, Michael J.
    Eichenfield, Lawrence F.
    Feeney, Claire
    Koppersteiner, Herwig
    Lazariciu, Irina
    Nesnas, John
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 31 - 31
  • [10] Impact of self-reported comorbid food allergy on efficacy and safety of abrocitinib and dupilumab in patients with moderate-to-severe atopic dermatitis: A pooled analysis of JADE COMPARE and JADE DARE
    Geng, B.
    Nosbaum, A.
    Boguniewicz, M.
    Vestergaard, C.
    Lazariciu, I.
    Feeney, C.
    Rebollo, F. J.
    Koppensteiner, H.
    Hernandez-Martin, I.
    [J]. ALLERGY, 2023, 78 : 140 - 140
12345